DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0153452 | Malignant neoplasm of gallbladder | GCNT2 | 2651 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | Q8N0V5 |
C0302592 | Cervix carcinoma | GCNT2 | 2651 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | Q8N0V5 |
C0699790 | Colon Carcinoma | GCNT2 | 2651 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | Q8N0V5 |
C0279626 | Squamous cell carcinoma of esophagus | GCNT2 | 2651 | glucosaminyl (N-acetyl) transferase 2 (I blood group) | Q8N0V5 |
C0342853 | Sialuria | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0023530 | Leukopenia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0023891 | Liver Cirrhosis, Alcoholic | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C2711227 | Steatohepatitis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0033860 | Psoriasis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1561643 | Chronic Kidney Diseases | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0020455 | Hypergammaglobulinemia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0028754 | Obesity | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0400966 | Non-alcoholic Fatty Liver Disease | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0011603 | Dermatitis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0019158 | Hepatitis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0019163 | Hepatitis B | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C2239176 | Liver carcinoma | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0008370 | Cholestasis | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0035078 | Kidney Failure | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C1096903 | Sialic Acid Storage Disease, Finnish Type (disorder) | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0040034 | Thrombocytopenia | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0019159 | Hepatitis A | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0007222 | Cardiovascular Diseases | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0023903 | Liver neoplasms | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
C0239946 | Fibrosis, Liver | SLC17A5 | 26503 | solute carrier family 17 member 5 | Q9NRA2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024